Dr. Ahmed M Malki received his PhD in Biochemistry in 2006 in the field of Molecular Oncology from Edison Institute of Biotechnology, Chemistry and Biochemistry Department, Ohio University in USA. He was awarded best publication from Chemistry and Biochemistry Department, Ohio University in 2005.
Dr. Maki held postdoctoral position at University of California Berkeley, USA via NIH grant in 2007. He was appointed as Head of Molecular therapeutics laboratories at City of Research and Technology. He received Best Research Award, Global Breast Cancer conference, 2011, Seoul, South Korea and Alexandria University Award for Scientific encouragement in 2012. He was also awarded international and national grants for discovery of novel small molecules targeting cancer cells; he has many peer reviewed international publications and He is serving in editorial board member in number of international journals.
Dr. Ahmed M Malki received his PhD in Biochemistry in 2006 in the field of Molecular Oncology from Edison Institute of Biotechnology, Chemistry and Biochemistry Department, Ohio University in USA. He was awarded best publication from Chemistry and Biochemistry Department, Ohio University in 2005.
Dr. Maki held postdoctoral position at University of California Berkeley, USA via NIH grant in 2007. He was appointed as Head of Molecular therapeutics laboratories at City of Research and Technology. He received Best Research Award, Global Breast Cancer conference, 2011, Seoul, South Korea and Alexandria University Award for Scientific encouragement in 2012. He was also awarded international and national grants for discovery of novel small molecules targeting cancer cells; he has many peer reviewed international publications and He is serving in editorial board member in number of international journals.
